New Age Exploration Limited (ASX:NAE) Requests Trading Halt
New Age Exploration Limited (ASX:NAE) requests a trading halt on the ASX pending a material capital raising announcement.
Tag: Regulatory News & Compliance
PainChek Limited (ASX:PCK) Releases Half Year Results
PainChek Limited (ASX:PCK) reports a 27% revenue increase in its half-year results, highlighting growth and expansion into the US market.
Neurotech International Ltd (ASX:NTI) Receives EMA Positive Opinion
Neurotech International Ltd (ASX:NTI) receives EMA positive opinion for NTI164 in Rett Syndrome, marking a key regulatory milestone.
Silk Logistics Holdings (ASX:SLH) Announces FY25 Half-Year Results and Acquisition Scheme
Silk Logistics (ASX:SLH) reports FY25 half-year financial results and announces an acquisition scheme with DP World Australia.
Telix Pharmaceuticals Limited (ASX:TLX) FDA Accepts BLA for TLX250-CDx
Telix Pharmaceuticals (ASX:TLX) announces FDA acceptance of BLA for TLX250-CDx, targeting kidney cancer imaging with a planned U.S. launch in 2025.
WiseTech Global Limited (ASX:WTC) Announces New Board Appointments
WiseTech Global (ASX:WTC) announces new board members and updates on governance and succession planning.
Light & Wonder, Inc. (ASX:LNW) Announces 2024 Performance and Strategic Acquisitions
Light & Wonder (ASX:LNW) reports 10% revenue growth in 2024, initiates significant share repurchases, and announces the acquisition of Grover Charitable Gaming.
OncoSil Medical Ltd (ASX:OSL) Delivers Key Milestones and Financial Growth in H1 2025
OncoSil Medical Ltd (ASX:OSL) achieves significant clinical and financial milestones, expanding its global presence and enhancing its financial position in H1 2025.
Besra Gold Inc (ASX:BEZ) Addresses Unauthorised Communications
Besra Gold Inc (ASX:BEZ) addresses unauthorised statements from Quantum Metals, clarifying gold resource figures and operational integrity.
Archer Materials Limited (ASX:AXE) Enhances Biochip Feasibility and Advances Development Roadmap
Archer Materials Limited (ASX:AXE) improves Biochip’s potassium detection accuracy, advances to human blood testing, and plans regulatory engagements.